Keros Therapeutics, Inc. - FORM S-1 - EX-21.1 - March 16, 2020

Attached files

file filename
EX-23.1 - EX-23.1 - Keros Therapeutics, Inc.d855212dex231.htm
EX-10.13 - EX-10.13 - Keros Therapeutics, Inc.d855212dex1013.htm
EX-10.12 - EX-10.12 - Keros Therapeutics, Inc.d855212dex1012.htm
EX-10.11 - EX-10.11 - Keros Therapeutics, Inc.d855212dex1011.htm
EX-10.10 - EX-10.10 - Keros Therapeutics, Inc.d855212dex1010.htm
EX-10.9 - EX-10.9 - Keros Therapeutics, Inc.d855212dex109.htm
EX-10.8 - EX-10.8 - Keros Therapeutics, Inc.d855212dex108.htm
EX-10.7 - EX-10.7 - Keros Therapeutics, Inc.d855212dex107.htm
EX-10.6 - EX-10.6 - Keros Therapeutics, Inc.d855212dex106.htm
EX-10.5 - EX-10.5 - Keros Therapeutics, Inc.d855212dex105.htm
EX-10.4 - EX-10.4 - Keros Therapeutics, Inc.d855212dex104.htm
EX-10.3 - EX-10.3 - Keros Therapeutics, Inc.d855212dex103.htm
EX-10.2 - EX-10.2 - Keros Therapeutics, Inc.d855212dex102.htm
EX-4.1 - EX-4.1 - Keros Therapeutics, Inc.d855212dex41.htm
EX-3.2 - EX-3.2 - Keros Therapeutics, Inc.d855212dex32.htm
EX-3.1 - EX-3.1 - Keros Therapeutics, Inc.d855212dex31.htm
S-1 - S-1 - Keros Therapeutics, Inc.d855212ds1.htm

Exhibit 21.1

Subsidiaries of Keros Therapeutics, Inc.

 

Name of Subsidiary

   

Jurisdiction of Organization

Keros Therapeutics Australia, Pty Ltd    Australia

Keros Therapeutics, Inc. Reports